Ncardia, a company specializing in human induced pluripotent stem cell (hiPSC) technology, has launched a new tool called Ncyte® Heart in a Box. This 3D cardiac microtissue model is designed to help researchers better understand heart development, disease, and potential treatments.
The model is made from hiPSCs and combines three key types of heart cells: ventricular cardiomyocytes, endothelial cells, and cardiac fibroblasts. By bringing these cells together, the system creates a microtissue that behaves more like a real human heart compared to traditional 2D cell cultures. This could make it a valuable tool for studying heart conditions, testing new drugs, and exploring personalized medicine.
Jeroen de Groot, Divisional CEO of Ncardia, shared his thoughts on the launch: “This is a big step forward for cardiac research. With Ncyte® Heart in a Box, researchers can study the heart in ways that weren’t possible before, which could lead to new treatments for heart disease.”
The tool is expected to be particularly useful for pharmaceutical companies and academic researchers working on heart-related therapies. By offering a more accurate way to model heart tissue, it could help speed up the development of new drugs and reduce the risk of unexpected side effects.